Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

28.81 -0.29 (-1.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 308,613
Open 28.96
Bid (Size) 26.18 (100)
Ask (Size) 29.45 (100)
Prev. Close 29.10
Today's Range 28.49 - 29.30
52wk Range 14.57 - 30.59
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Fulgent to Participate in Upcoming Conferences
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
FULGENT GENETICS INC (NASDAQ:FLGT) Beats Q3 2025 Earnings Estimates and Raises Guidance ↗
Fulgent Genetics Q3 2025 earnings beat expectations with a surprise profit, causing a 4% pre-market stock surge. The company also raised its full-year guidance. 
Via Chartmill
Topics Earnings

Performance

YTD
+56.4%
+56.4%
1 Month
+27.0%
+27.0%
3 Month
+33.9%
+33.9%
6 Month
+35.8%
+35.8%
1 Year
+72.4%
+72.4%

More News

Read More
News headline image
Fulgent Reports Third Quarter 2025 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics's Earnings Outlook ↗
Via Benzinga
News headline image
Fulgent Genetics Earnings Preview ↗
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2025 ↗
Via Benzinga
News headline image
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics: A Risky Bet or a Hidden Gem? ↗
Via The Motley Fool
News headline image
Fulgent (FLGT) Q2 Revenue Jumps 16% ↗
Via The Motley Fool
News headline image
Why Fulgent Genetics Stock Was Crushing It on Friday ↗
Via The Motley Fool
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Fulgent Reports Second Quarter 2025 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 1, 2025 ↗
Via Benzinga
News headline image
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Via ACCESS Newswire

Frequently Asked Questions

Is Fulgent Genetics, Inc. - Common Stock publicly traded?
Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
What is the current price of Fulgent Genetics, Inc. - Common Stock?
The current price of Fulgent Genetics, Inc. - Common Stock is 28.81
When was Fulgent Genetics, Inc. - Common Stock last traded?
The last trade of Fulgent Genetics, Inc. - Common Stock was at 11/17/25 04:00 PM ET
What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
The market capitalization of Fulgent Genetics, Inc. - Common Stock is 862.19M
How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
Fulgent Genetics, Inc. - Common Stock has 862M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.